Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.33 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13154072 | 0.69 | MEN1 (0.39) | MAPTSMN1; SMN2GAA | |
| SCHEMBL673556 | 0.69 | TSHR (0.44) | TSHRMAPTSMN1; SMN2PDK1PDK2 | |
| SCHEMBL2081025 | 0.68 | KDM4C (0.52) | TSHRMAPTSMN1; SMN2GAA | |
| SCHEMBL17147985 | 0.67 | SSTR4 (0.39) | MAPTSMN1; SMN2GAA | |
| SCHEMBL18518150 | 0.66 | MEN1 (0.36) | SMN1; SMN2 | |
| SCHEMBL22233553 | 0.66 | SIGMAR1 (0.32) | — | |
| SCHEMBL22233465 | 0.66 | SIGMAR1 (0.32) | — | |
| SCHEMBL217915 | 0.65 | — | — | |
| SCHEMBL1234217 | 0.65 | — | — | |
| SCHEMBL19151295 | 0.65 | MEN1 (0.34) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067504-B2 | Acrylic pressure-sensitive adhesives with acylaziridine crosslinking agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-8067504-B2 | Acrylic pressure-sensitive adhesives with acylaziridine crosslinking agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110054115-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-03-03 | — | — | US | disclosed |
| US-20110054115-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054115-A1 | ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH ACYLAZIRIDINE CROSSLINKING AGENTS | AAAS, PTK2, MDN1 | TSHR 4840/4885MAPT 2592/4885SMN1; SMN2 2721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.